Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 14, 2022 12:32PM
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
5
|
Zenith Epigenetics
|
Apr 24, 2022 11:28AM
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
4
|
Zenith Epigenetics
|
Apr 14, 2022 06:46AM
|
Re: RVX's place in therapy - future prediction
|
6
|
Resverlogix Corp.
|
Mar 14, 2021 11:07AM
|
Re: RVX Webcast 9/10 10:25 AM (EST) at Rodman and Renshaw
|
6
|
Resverlogix Corp.
|
Sep 06, 2015 04:12PM
|
Re: RVX tweet from Nov 7th
|
4
|
Resverlogix Corp.
|
Nov 12, 2016 06:01PM
|
Re: RVX News (Events) are being picked up in USA
|
7
|
Resverlogix Corp.
|
Oct 05, 2016 09:03AM
|
Re: RVX Current Status
|
10
|
Resverlogix Corp.
|
Feb 27, 2020 02:07PM
|
Re: RVX buyout projection at $30 US minimum
|
4
|
Resverlogix Corp.
|
Nov 02, 2018 12:57PM
|
Re: RVX Board Thoughts Mar 18 2022 – Wishful Thinking
|
13
|
Resverlogix Corp.
|
Mar 19, 2022 01:31PM
|
Re: RVX Announces Update Webcast and Conference Call
|
8
|
Resverlogix Corp.
|
Jan 26, 2021 07:36PM
|
Re: RVX Announces Update Webcast and Conference Call
|
6
|
Resverlogix Corp.
|
Jan 18, 2021 04:05PM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
8
|
Resverlogix Corp.
|
May 10, 2022 04:46PM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
3
|
Resverlogix Corp.
|
May 09, 2022 11:22AM
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
4
|
Resverlogix Corp.
|
May 09, 2022 12:27PM
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
1
|
Resverlogix Corp.
|
Dec 05, 2016 01:36PM
|
Re: RVV insider purchases
|
5
|
Resverlogix Corp.
|
Dec 16, 2022 10:28AM
|
Re: RVV insider purchases
|
3
|
Resverlogix Corp.
|
Dec 17, 2022 11:03AM
|
Re: Rumors starting again
|
3
|
Zenith Epigenetics
|
Nov 12, 2020 01:59PM
|
Re: Rules of thumb and broken thumbs...
|
7
|
Resverlogix Corp.
|
Sep 29, 2020 09:09AM
|